Actively Recruiting

Phase Not Applicable
Age: 60Years +
All Genders
ID07084142

Developing a Digital Shared Decision-Making Aid to Improve Patient-Centered Outcomes in Implantable Cardioverter-Defibrillator (ICD) Decisions Among Older Patients

Led by Stanford University · Updated on 2026-04-27

600

Participants Needed

2

Research Sites

78 weeks

Total Duration

On this page

Sponsors

S

Stanford University

Lead Sponsor

N

National Heart, Lung, and Blood Institute (NHLBI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Advanced heart failure affects millions and carries a high risk of sudden cardiac death due to abnormal heart electrical activity. This study focuses on creating a digital decision aid to help older heart failure patients make informed choices about implanting an Implantable Cardioverter-Defibrillator (ICD), a device that can prevent sudden death but has significant drawbacks. Researchers will gather insights through surveys, interviews, and focus groups to guide the development of this digital tool, which will later be tested in a randomized clinical trial against usual care. Participants will use one of three options: a patient-facing app with personalized risk information, the same app without personalized risk data, or receive usual care without the app. The digital aid includes clinical data input, educational videos, quizzes, risk exploration, and a worksheet to support shared decision-making between patients and clinicians. The study involves iterative app development with repeated user testing and will include multiple clinical sites after initial development. During the study, participants will complete surveys, interviews, and focus groups to provide feedback on the app and decision-making process. Researchers will collect demographic and health information and track reasons for participation or ineligibility. The main outcome measured is the Decisional Conflict Scale immediately after the decision visit and at three months. The study is expected to continue through early 2028, with ongoing refinement of the digital tool based on participant input.

CONDITIONS

Brief Title

Developing a Digital Aid to Improve ICD Decisions

Who Can Participate

Age: 60Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Meets or approximates minimal criteria for primary prevention ICD placement with left ventricular ejection fraction less than 35%
  • Clinical diagnosis of heart failure with severe ischemic or nonischemic dilated cardiomyopathy and NYHA Class II or III heart failure
  • Age 70 years or older
  • Able to consent and follow study instructions in English, Mandarin, or Spanish
Not Eligible

You will not qualify if you...

  • Previous ICD implantation (excluding pacemakers)
  • Indication for secondary prevention ICD implantation
  • History of mechanical heart valve replacement
  • Recent myocardial infarction within 40 days
  • Recent revascularization within 90 days
  • Familial or genetic disorders with high risk of ventricular arrhythmias such as long QT syndrome or hypertrophic cardiomyopathy
  • Any contraindications to ICD placement
  • Life expectancy less than 6 months or other clinical considerations
  • Unwilling or unable to consider ICD placement
  • Any contraindications to ambulatory participation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - Varies per participant until decision-making visit

Participants use a digital decision-making app before a clinical visit to help decide on ICD placement. Some apps provide personalized risk information while others provide generic information. Usual clinical care participants do not use the app.

1 baseline visit and 1 decision-making visit

Post-operative Follow-up

Duration - Up to 3 months after ICD implantation

Participants who undergo ICD implantation as part of their routine medical care are observed for outcomes after the procedure.

Approximately 2 follow-up visits

Trial Site Locations

Total: 2 locations

1

University of California, San Francisco

San Francisco, California, United States, 94143

Actively Recruiting

2

Eastern Carolina University

Greenville, North Carolina, United States, 27858

Actively Recruiting

Loading map...

Research Team

R

Randall S Stafford, MD, PhD, MHS

D

Darlyne Esparza

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

3

Similar Trials

Randomised Investigation of Physiological, Conventional and ...

Heart Failure and Reduced Ejection Fraction

Actively Recruiting

1 location

Broaden Accessibility of Breakthrough Treatment for Heart Fa...

Heart Failure and Reduced Ejection Fraction

Actively Recruiting

1 location

Secondary Mitral Regurgitation Treatment With MitraClip and ...

Heart Failure and Reduced Ejection Fraction

Actively Recruiting

6 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here